News
Investors Could Be Underestimating Netflix's Biggest Growth Opportunity
After growing like a weed during the pandemic-induced lockdowns, Netflix (NASDAQ: NFLX) fell on hard times. The combination of tough year-over-year comparisons and slowing growth, plus an ill-timed
Should Samsung Buy This Longtime Technology Partner?
Digital display technologist Universal Display (NASDAQ: OLED) renewed a long-standing contract with top customer Samsung (OTC: SSNL.F) this week. These partners are getting so inseparable, you'd
2 Stocks in the Hot Seat Going into 2023
There is a stark difference between broken stocks -- where a company's stock is plummeting but the business is still thriving -- and struggling businesses. Struggling businesses where the share
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
Revolutionary stocks can be new or old, big or small, but they need novel ideas to break away from other companies, or at least the capacity to take new ideas to another level. Eli Lilly (NYSE: LLY)
These Nasdaq Retail Stocks Are Sending Mixed Signals
Investors were hoping for some relief on Wall Street on Thursday morning as the stock market tried to recover from losses earlier in the week. The Nasdaq Composite (NASDAQINDEX: ^IXIC) opened
Here's Why Starbucks Stock Popped 18% in November
Shares of coffee giant Starbucks (NASDAQ: SBUX) popped 18% in November, according to data provided by S&P Global Market Intelligence. The company kicked off the month with solid financial results
2 Best Medical Device Stocks for 2023
Medtech has long been a highly profitable area for investors. As the space has matured and grown more competitive, however, investors have had to become more cautious when picking stocks in this
Is Gilead Sciences a Buy?
Gilead Sciences (NASDAQ: GILD) is a top healthcare company that generates the bulk of its revenue from medicine that treats HIV. And it has an exciting new treatment in lenacapavir that, if it
2 Forever Stocks You Can Buy and Forget About
If you're investing for the very long term (i.e., forever), then the good news is you don't need to worry about what's happening with the economy. Over the years, the economy has recovered from
Why Consolidated Edison Stock Jumped 11% in November
Shares of Consolidated Edison (NYSE: ED) rose 11.4% in November, according to data provided by S&P Global Market Intelligence. Powering the utility stock higher was its better-than-expected
Buy This Dirt-Cheap Dividend Growth Machine and Thank Yourself Later
Market volatility is a double-edged sword. On one hand, the stock market downturns that it causes can lead investors to lose sleep at night and make rash decisions.
But on the other hand, sudden and
Starry-Eyed Investors Should Be Cautious About AST SpaceMobile
Unlike other tradable businesses engaged in the "space race," AST SpaceMobile (NASDAQ: ASTS) doesn't send celebrities into orbit. Rather, it's a company with an ambitious vision: to bring 5G network
VinFast Chooses T-Mobile as Exclusive Global Connectivity Provider for Electric Vehicles
Today, T-Mobile (NASDAQ: TMUS) and VinFast announced an agreement for the Un-carrier to be the exclusive provider of connectivity for VinFast's smart electric vehicles in North America and Europe
3 Tech Growth Stocks With More Potential Than Any Cryptocurrency
As bad as the stock market is this year, cryptocurrencies have been worse. In fact, every asset class is doing better than crypto, and you can just about throw a dart at a list of stocks these days
Investors Could Be Underestimating Disney's Biggest Growth Engine
When it comes to multimedia entertainment, no one can hold a candle to The Walt Disney Company (NYSE: DIS). Its reach is unparalleled, from feature films to television stations, theme parks
Where Will Prologis Be in 1 Year?
Shares of real estate investment trust (REIT) Prologis (NYSE: PLD) have fallen over 30% so far in 2022. That type of drop might suggest that the warehouse landlord is facing material difficulties
Ulta Beauty Stock Is Up 16% in 2022, and It Still Has Room to Run
Since hitting a 52-week low of $330 earlier this year, Ulta Beauty (NASDAQ: ULTA) stock is up 45% at the time of writing. Year to date, its 16% gain significantly outperforms the S&P 500 index loss
Is CRISPR Therapeutics a Buy?
CRISPR Therapeutics (NASDAQ: CRSP) is a compelling investment because of the potential it has as it works on developing gene-editing therapies that could be game changers and revolutionize the
Is Opendoor Still the Future of Real Estate?
It's been a rough year for instant buyers, aka iBuyers, with shares of leading iBuyer Opendoor Technologies (NASDAQ: OPEN) down by more than 90% so far in 2022 and major players like Zillow (NASDAQ:
2 Top-Tech Stocks Ready for a Bull Run
This year has been a disappointment to say the least for investors. After a 13-year bull-market run driven primarily by the tech-heavy Nasdaq 100, growth stocks have tanked this year, and the index
Prediction: These 2 Stocks Will Soar in 2023
It's been an ugly year for the stock market. The S&P 500, Nasdaq Composite, and Dow Jones Industrial Average have lost 16%, 28%, and 6%, respectively, year to date. For the Nasdaq, it's the worst
Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, announced today the FDA has cleared the next-generation Dexcom G7 Continuous
Wow! Buffet Stock Taiwan Semiconductor Manufacturing Is Making Big Moves in the USA
Today's video focuses on Taiwan Semiconductor Manufacturing (NYSE: TSM) and its recent investment updates in Arizona that can create tailwinds for the semiconductor industry. Check out the short
2 Warren Buffett Stocks to Buy Before 2022 Ends and 1 to Avoid
Warren Buffett is one of the most successful stock investors of all time, which makes the quarterly regulatory filings from his conglomerate, Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B), an
This Monster Dividend Stock Isn't Done Growing
Johnson & Johnson (NYSE: JNJ) is in the midst of a transition. The company is spinning off its consumer health business next year, allowing the remaining entity to focus more on growth initiatives